Trial intelligence / Profile preview

Ethinylestradiol/Dienogest for Endometrial Preparation Before Hysteroscopic Polypectomy

NCT06316206Phase 4Completed

Sponsor
University of Palermo
Start
Jan 2023
Primary completion
Aug 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of ethinyl estradiol and dienogest in endometrial polyp, sponsored by University of Palermo. Primary endpoint: Quality of endometrial preparation at 14 days. Started Jan 2023; status: completed.

02

Drugs

ethinyl estradioldienogest
03

Conditions

endometrial polyp

Beyond the preview

Go deeper on NCT06316206.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06316206.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call